High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses - Institut Pasteur Access content directly
Journal Articles Journal of visualized experiments : JoVE Year : 2014

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Abstract

RNA viruses are responsible for major human diseases such as flu, bronchitis, dengue, Hepatitis C or measles. They also represent an emerging threat because of increased worldwide exchanges and human populations penetrating more and more natural ecosystems. A good example of such an emerging situation is chikungunya virus epidemics of 2005-2006 in the Indian Ocean. Recent progresses in our understanding of cellular pathways controlling viral replication suggest that compounds targeting host cell functions, rather than the virus itself, could inhibit a large panel of RNA viruses. Some broad-spectrum antiviral compounds have been identified with host target-oriented assays. However, measuring the inhibition of viral replication in cell cultures using reduction of cytopathic effects as a readout still represents a paramount screening strategy. Such functional screens have been greatly improved by the development of recombinant viruses expressing reporter enzymes capable of bioluminescence such as luciferase. In the present report, we detail a high-throughput screening pipeline, which combines recombinant measles and chikungunya viruses with cellular viability assays, to identify compounds with a broad-spectrum antiviral profile.

Dates and versions

pasteur-01113538 , version 1 (05-02-2015)

Identifiers

Cite

Marianne Lucas-Hourani, Hélène Munier-Lehmann, Olivier Helynck, Anastassia Komarova, Philippe Desprès, et al.. High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses. Journal of visualized experiments : JoVE, 2014, 87, pp.e51222. ⟨10.3791/51222⟩. ⟨pasteur-01113538⟩
101 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More